References
- Garshasbi M, Oberkanins C, Law HY, et al. α-Globin gene deletion and point mutation analysis among in Iranian patients with microcytic hypochromic anemia. Haematologica. 2003;88(10):1196–1197
- Hadavi V, Taromchi AH, Malekpour M, et al. Elucidating the spectrum of α-thalassemia mutations in Iran. Haematologica. 2007;92(7):992–993
- Nozari G, Rahbar S, Golshaiyzan A, Rahmanzadeh S. Molecular analyses of β-thalassemia in Iran. Hemoglobin. 1995;19(6):425–431
- Yavarian M, Harteveld CL, Batelaan D, et al. Molecular spectrum of β-thalassemia in the Iranian province of Hormozgan. Hemoglobin. 2001;25(1):35–43
- Najmabadi H, Karimi-Nejad R, Sahebjam S, et al. The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin. 2001;25(3):285–296
- Chui DHK, Waye JS. Hydrops fetalis caused by α-thalassemia: an emerging health care problem. Blood. 1998;91(7):2213–2222
- Kanavakis E, Papassotiriou I, Karagiorga M, et al. Phenotypic and molecular diversity of Haemoglobin H disease: a Greek experience. Br J Haematol. 2000;111(3):915–923
- Galanello R, Aru B, Dessi C, et al. Hb H disease in Sardinia: molecular, hematological and clinical aspects. Acta Haematol. 1992;88(1):1–6
- Oron-Karni V, Filon D, Shifrin Y, et al. Diversity of α-globin mutations and clinical presentation of α-thalassemia in Israel. Am J Hematol. 2000;65(3):196–203
- Baysal E, Kleanthous M, Bozkurt G, et al. α-Thalassaemia in the population of Cyprus. Br J Haematol. 1995;89(3):496–499
- Oner C, Gürgey A, Oner R, et al. The molecular basis of Hb H disease in Turkey. Hemoglobin. 1997;21(1):41–51
- Fichera M, Spalletta A, Fiorenza F, et al. Molecular basis of α-thalassemia in Sicily. Hum Genet. 1997;99(3):381–386
- Zorai A, Abbes S, Prehu C, et al. Hb H disease among Tunisians: Molecular characterization of α-thalassemia determinants and hematological findings. Hemoglobin. 2003;27(1):57–61
- Villegas A, Ropero P, Gonzalez FA, et al. The thalassemia syndromes: molecular characterization in the Spanish population. Hemoglobin. 2001;25(3):273–283
- Laosombat V, Viprakasit V, Chotsampancharoen T, et al. Clinical features and molecular analysis in Thai patients with Hb H disease. Ann Hematol. 2009;88(12):1185–1192
- Harteveld CL, Higgs DR. α-Thalassaemia. Orphanet J Rare Dis. 2010;5:13. doi. 10.1186/1750-1172-5-13
- Neishabury M, Oberkanins C, Moheb LA, et al. High prevalence of the −α3.7 deletion among thalassemia patients in Iran. Hemoglobin. 2003;27(1):53–55
- Najmabadi H, Ghamari A, Sahebjam F, et al. Fourteen-year experience of prenatal diagnosis of thalassemia in Iran. Community Genet. 2006;9(2):93–97
- Najmabadi H, Pourfathollah AA, Neishabury M, et al. Rare and unexpected mutations among Iranian β-thalassemia patients and prenatal samples discovered by reverse-hybridization and DNA sequencing. Haematologica. 2002;87(10):1113–1114
- Fallah MS, Samavat A, Zeinali S. Iranian national program for the prevention of thalassemia and prenatal diagnosis: Mandatory premarital screening and legal medical abortion. Prenat Diagn. 2009;29(13):1285–1286
- Ebrahimkhani S, Azarkeivan A, Bayat N, et al. Genotype-phenotype correlation in Iranian patients with Hb H disease. Hemoglobin. 2011;35(1):40–46
- Pornprasert S, Kasemrad C, Sukunthamala K. Diagnosis of thalassemia on dried blood spot samples by high performance liquid chromatography. Hemoglobin. 2010;34(5):486–494
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215
- Baysal E, Huisman THJ. Detection of common deletional α-thalassemia-2 determinants by PCR. Am J Hematol. 1994;46(3):208–213
- Giambona A, Passarello C, Renda D, Maggio A. The significance of the Hemoglobin A2 value in screening for hemoglobinopathies. Clin Biochem. 2009;42(18):1786–1796
- Hadavi V, Jafroodi M, Hafezi-Nejad N, et al. α-Thalassemia mutations in Gilan Province, North Iran. Hemoglobin. 2009;33(3):235–241
- Tamaddoni A, Hadavi V, Nejad NH, et al. α-Thalassemia mutation analyses in Mazandaran Province, North Iran. Hemoglobin. 2009;33(2):115–123
- Zandian K, Nateghi J, Keikhaie B, et al. α-Thalassemia mutations in Khuzestan Province, Southwest Iran. Hemoglobin. 2008;32(6):546–552
- Huisman THJ, Carver MFH, Baysal E, Eds. A Syllabus of Thalassemia Mutations (1997). Augusta: The Sickle Cell Anemia Foundation, 1997
- Bayat N, Farashi S, Hafezi-Nejad N, et al. Novel mutations responsible for α-thalassemia in Iranian families. Hemoglobin. 2013;37(2):148–159
- Schrier SL, Bunyaratvej A, Khuhapinant A, et al. The unusual pathobiology of Hemoglobin Constant Spring red blood cells. Blood. 1997;89(5):1762–1769
- Tan JA, Kok JL, Tan KL, et al. Thalassemia intermedia in Hb H-CS disease with compound heterozygosity for β-thalassemia: Challenges in hemoglobin analysis and clinical diagnosis. Genes Genet Syst. 2009;84(1):67–71
- Oner R, Altay Ç, Gürgey A, et al. β-Thalassemia in Turkey. Hemoglobin. 1990;14(1):1–13
- Kan YW, Nathan DG. Mild thalassemia: The result of interactions of α and β thalassemia genes. J Clin Invest. 1970;49(4):635–642